Correlation Between Aerovate Therapeutics and Odyssey Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Odyssey Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Odyssey Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Odyssey Group International, you can compare the effects of market volatilities on Aerovate Therapeutics and Odyssey Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Odyssey Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Odyssey Group.

Diversification Opportunities for Aerovate Therapeutics and Odyssey Group

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aerovate and Odyssey is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Odyssey Group International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Odyssey Group Intern and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Odyssey Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Odyssey Group Intern has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Odyssey Group go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Odyssey Group

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Odyssey Group. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 2.02 times less risky than Odyssey Group. The stock trades about -0.02 of its potential returns per unit of risk. The Odyssey Group International is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  4.50  in Odyssey Group International on December 4, 2024 and sell it today you would lose (3.31) from holding Odyssey Group International or give up 73.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.59%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Odyssey Group International

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Odyssey Group Intern 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Odyssey Group International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Aerovate Therapeutics and Odyssey Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Odyssey Group

The main advantage of trading using opposite Aerovate Therapeutics and Odyssey Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Odyssey Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Odyssey Group will offset losses from the drop in Odyssey Group's long position.
The idea behind Aerovate Therapeutics and Odyssey Group International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data